Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Wilcken

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
Journal of Inherited Metabolic Disease|June 19, 2001
Rare diseases and the assessment of intervention: what sorts of clinical trials can we use?B Wilcken
The Southeast Asian Journal of Tropical Medicine and Public Health|June 13, 2001
Ethical and social issues in newborn screeningB Wilcken
Pediatric Pulmonology|October 17, 1998
Neonatal screening for cystic fibrosis: it is timeB Wilcken
Journal of Inherited Metabolic Disease|March 14, 2008
The consequences of extended newborn screening programmes: do we know who needs treatment?B Wilcken
Journal of Inherited Metabolic Disease|March 8, 2007
Recent advances in newborn screeningB Wilcken
Progress in Clinical and Biological Research|January 1, 1987
An evaluation of screening for cystic fibrosisB Wilcken
The Southeast Asian Journal of Tropical Medicine and Public Health|June 13, 2001
Neonatal screening in AustraliaB Wilcken
Lancet (London, England)|February 1, 1975
Letter: Incidence of homocystinuriaB Wilcken
The Medical Journal of Australia|October 13, 1984
Homozygous cystinuria in New South Wales. A study of 110 individuals with cystinuria ascertained by methods other than neonatal screeningA Smith, B Wilcken
Archives of Disease in Childhood|March 1, 1978
Homocystinuria in New South WalesB Wilcken, G Turner
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Journal of Inherited Metabolic Disease|June 19, 2001
Rare diseases and the assessment of intervention: what sorts of clinical trials can we use?B Wilcken
The Southeast Asian Journal of Tropical Medicine and Public Health|June 13, 2001
Ethical and social issues in newborn screeningB Wilcken
Pediatric Pulmonology|October 17, 1998
Neonatal screening for cystic fibrosis: it is timeB Wilcken
Journal of Inherited Metabolic Disease|March 14, 2008
The consequences of extended newborn screening programmes: do we know who needs treatment?B Wilcken
Journal of Inherited Metabolic Disease|March 8, 2007
Recent advances in newborn screeningB Wilcken
Progress in Clinical and Biological Research|January 1, 1987
An evaluation of screening for cystic fibrosisB Wilcken
The Southeast Asian Journal of Tropical Medicine and Public Health|June 13, 2001
Neonatal screening in AustraliaB Wilcken
Lancet (London, England)|February 1, 1975
Letter: Incidence of homocystinuriaB Wilcken
The Medical Journal of Australia|October 13, 1984
Homozygous cystinuria in New South Wales. A study of 110 individuals with cystinuria ascertained by methods other than neonatal screeningA Smith, B Wilcken
Archives of Disease in Childhood|March 1, 1978
Homocystinuria in New South WalesB Wilcken, G Turner
Pageof 13